These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12405945)

  • 1. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410.
    Elston CW; Ellis IO
    Histopathology; 2002 Sep; 41(3A):151-2, discussion 152-3. PubMed ID: 12405945
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of mitotic counts in the grading and prognosis of the breast cancer.
    Patel C; Sidhu KP; Shah MJ; Patel SM
    Indian J Pathol Microbiol; 2002 Jul; 45(3):247-54. PubMed ID: 12785160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.
    Schmidt M; Lewark B; Kohlschmidt N; Glawatz C; Steiner E; Tanner B; Pilch H; Weikel W; Kölbl H; Lehr HA
    Breast Cancer Res; 2005; 7(2):R256-66. PubMed ID: 15743506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.
    Skaland I; van Diest PJ; Janssen EA; Gudlaugsson E; Baak JP
    Hum Pathol; 2008 Apr; 39(4):584-90. PubMed ID: 18291440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of prognostic factors in breast cancer EC I-II and the importance of local recurrence].
    Castillero C
    Rev Med Panama; 2001; 26():35-9. PubMed ID: 16161722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer.
    Suen D; Chow LW
    Biomed Pharmacother; 2006 Jul; 60(6):293-7. PubMed ID: 16828252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of prognostic factors in premenopausal women with breast cancer.
    Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L
    Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.
    Molina R; Filella X; Zanon G; Pahisa J; Alicarte J; Munoz M; Farrus B; Ballesta AM
    Anticancer Res; 2003; 23(2A):1043-50. PubMed ID: 12820345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours.
    Fiets WE; Bellot FE; Struikmans H; Blankenstein MA; Nortier JW
    Eur J Surg Oncol; 2005 Mar; 31(2):128-33. PubMed ID: 15698727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
    Evans AJ; Rakha EA; Pinder SE; Green AR; Paish C; Ellis IO
    J Med Screen; 2007; 14(4):210-4. PubMed ID: 18078567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
    Elston CW; Ellis IO
    Histopathology; 2002 Sep; 41(3A):154-61. PubMed ID: 12405947
    [No Abstract]   [Full Text] [Related]  

  • 14. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
    Kim SH; Cha ES; Kim HS; Kang BJ; Choi JJ; Jung JH; Park YG; Suh YJ
    J Magn Reson Imaging; 2009 Sep; 30(3):615-20. PubMed ID: 19711411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
    Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases.
    Caly M; Genin P; Ghuzlan A A; Elie C; Fréneaux P; Klijanienko J; Rosty C; Sigal-Zafrani B; Vincent-Salomon A; Douggaz A; Zidane M; Sastre-Garau X
    Anticancer Res; 2004; 24(5B):3283-8. PubMed ID: 15510624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of necrosis in Nigerian breast cancer.
    Ikpatt O; Ndoma-Egba R; Collan Y
    Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
    Ko SS; Na YS; Yoon CS; Park JY; Kim HS; Hur MH; Lee HK; Chun YK; Kang SS; Park BW; Lee JH
    Int J Surg Pathol; 2007 Apr; 15(2):98-109. PubMed ID: 17478762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.
    Gabos Z; Sinha R; Hanson J; Chauhan N; Hugh J; Mackey JR; Abdulkarim B
    J Clin Oncol; 2006 Dec; 24(36):5658-63. PubMed ID: 17102066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.